» Articles » PMID: 24952892

A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia

Overview
Date 2014 Jun 23
PMID 24952892
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

[18F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely used diagnostic tool that can detect and quantify pathophysiology, as assessed through changes in cerebral glucose metabolism. [18F]-FDG PET scans can be analyzed using voxel-based statistical methods such as Statistical Parametric Mapping (SPM) that provide statistical maps of brain abnormalities in single patients. In order to perform SPM, a "spatial normalization" of an individual's PET scan is required to match a reference PET template. The PET template currently used for SPM normalization is based on [15O]-H2O images and does not resemble either the specific metabolic features of [18F]-FDG brain scans or the specific morphological characteristics of individual brains affected by neurodegeneration. Thus, our aim was to create a new [18F]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both age-matched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template-at the single-subject and group level-independently for subjects with Mild Cognitive Impairment (MCI), probable Alzheimer's Disease (AD), Frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB). We found a significant statistical effect of the population-specific FDG template-based normalisation in key anatomical regions for each dementia subtype, suggesting that spatial normalization with the new template provides more accurate estimates of metabolic abnormalities for single-subject and group analysis, and therefore, a more effective diagnostic measure.

Citing Articles

Automated quantification of brain PET in PET/CT using deep learning-based CT-to-MR translation: a feasibility study.

Kim D, Choo K, Lee S, Kang S, Yun M, Yang J Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39964542 DOI: 10.1007/s00259-025-07132-2.


Early-phase F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer's disease: a comparison with F-FDG-PET and early-phase amyloid-PET.

Boccalini C, Peretti D, Mathoux G, Iaccarino L, Ribaldi F, Scheffler M Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39849149 DOI: 10.1007/s00259-024-07063-4.


Identification of a metabolic brain network characterizing essential tremor.

Volnov S, Baagil H, Winz O, Kaiser H, Meles S, Schulz J Sci Rep. 2025; 15(1):2138.

PMID: 39820101 PMC: 11739557. DOI: 10.1038/s41598-024-82069-4.


Sex-related differences in amyotrophic lateral sclerosis: A 2-[F]FDG-PET study.

Canosa A, Martino A, Manera U, Giuliani A, Vasta R, Palumbo F Eur J Neurol. 2024; 32(1):e16588.

PMID: 39655539 PMC: 11629101. DOI: 10.1111/ene.16588.


Assessing the metabolism of the olfactory circuit by use of F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer's disease or frontotemporal dementia.

Loewenstein D, van Grinsven M, de Pont C, Dautzenberg P, van Strien A, Henssen D Alzheimers Res Ther. 2024; 16(1):241.

PMID: 39472983 PMC: 11520854. DOI: 10.1186/s13195-024-01604-7.


References
1.
Crivello F, Schormann T, Tzourio-Mazoyer N, Roland P, Zilles K, Mazoyer B . Comparison of spatial normalization procedures and their impact on functional maps. Hum Brain Mapp. 2002; 16(4):228-50. PMC: 6871934. DOI: 10.1002/hbm.10047. View

2.
Morbelli S, Drzezga A, Perneczky R, Frisoni G, Caroli A, van Berckel B . Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging. 2012; 33(11):2533-50. DOI: 10.1016/j.neurobiolaging.2012.01.005. View

3.
Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G . Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage. 1999; 9(1):63-80. DOI: 10.1006/nimg.1998.0381. View

4.
Berti V, Osorio R, Mosconi L, Li Y, De Santi S, de Leon M . Early detection of Alzheimer's disease with PET imaging. Neurodegener Dis. 2010; 7(1-3):131-5. PMC: 3214828. DOI: 10.1159/000289222. View

5.
Foster N, Heidebrink J, Clark C, Jagust W, Arnold S, Barbas N . FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain. 2007; 130(Pt 10):2616-35. DOI: 10.1093/brain/awm177. View